ZHOU Weiwen 1,3 , GE Long 1,2 , XU Junfeng 1,2 , SHI Xintong 1,2 , LIANG Li 1,2 , AN Ni 1,2 , LIU Yinchun 1,2 , LI Yarui 1,3 , MA Jichun 1 , NA Heya 1 , TIAN Jinhui 1
  • 1. School of Basic Sciences of Lanzhou University, Evidence-Based Medicine Center of Lanzhou University, Lanzhou 730000, China;2. The First Clinical Medicine College, Lanzhou University, Lanzhou 730000, China;3. The Second Clinical Medicine College, Lanzhou University, Lanzhou 730000, China;
TIAN Jinhui, Email: tianjh@lzu.edu.cn
Export PDF Favorites Scan Get Citation

Objective  To assess the reporting quality of systematic reviews/meta-analyses related to interventions published in Chinese Journal of Evidence-Based Medicine by PRISMA guidelines, and to analyze its influencing factors.
Methods  The systematic reviews/meta-analyses related to interventions were searched in the Chinese Journal of Evidence-Based Medicine from its inception to 2011. The quality of the included reviews was assessed in accordance with the PRISMA checklist. Based on the degree of conformity with each criterion of PRISMA, the reviews were scored as “1”, “0.5” or “0” orderly. The data were put into Excel, and the Meta-analyst software was used for statistical analysi.
Results  Among all literature in the volume 11 (95) of the Chinese Journal of Evidence-Based Medicine from 2001 to 2011, a total of 379 studies were included, and the number of publication showed a yearly rising trend. The PRISMA scale score ranged from 8.5 to 26 (X±SD) was 19.97±3.15. Among all studies, 25 (6.60%) scored 21-27 points, which were regarded as the complete reporting; 226 (59.63%) scored 15-21 points, regarded as relatively complete reporting; and 128 (33.77%) scored less than 15 points, regarded as serious lack of information. The results of stratified analysis showed that, both the issue of PRISMA and fund support could improve the reporting quality, with a significant difference (P lt;0.05); and authors more than 3, authors from universities, and authors from more than 2 institutions could improve the reporting quality, but without a significant difference (P gt;0.05).
Conclusion  The overall reporting quality of systematic reviews/meta-analyses related to interventions published in the Chinese Journal of Evidence-Based Medicine is poor, and it is influenced by the factors of protocol and registration, risk of bias across studies, other analyses, and fund support, which have to be taken seriously. The reasonable utilization of the PRISMA checklist will improve the reporting quality of systematic reviews/meta-analyses.

Citation: ZHOU Weiwen,GE Long,XU Junfeng,SHI Xintong,LIANG Li,AN Ni,LIU Yinchun,LI Yarui,MA Jichun,NA Heya,TIAN Jinhui. Quality Evaluation on the Systematic Reviews/Meta-Analyses Related to Interventions Published in the Chinese Journal of Evidence-Based Medicine. Chinese Journal of Evidence-Based Medicine, 2013, 13(4): 482-488. doi: 10.7507/1672-2531.20130082 Copy

  • Previous Article

    Effectiveness of Chinese Herbal Retention Enema in Viral Hepatitis Patients: A Meta-Analysis
  • Next Article

    Evidence-Based Research on Rural Primary Physicians Training Modes in Gansu Province